Impact of chronic sleep restriction on sleep continuity, sleep structure, and neurobehavioral performance.
EEG
chronic sleep restriction
performance
sleep
sleep quality
Journal
Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084
Informations de publication
Date de publication:
11 07 2022
11 07 2022
Historique:
received:
15
02
2021
revised:
15
02
2022
pubmed:
27
2
2022
medline:
14
7
2022
entrez:
26
2
2022
Statut:
ppublish
Résumé
Chronic sleep restriction (CSR) has been associated with adverse effects including cognitive impairment and increased risk of diabetes and cardiovascular disease. Yet, sleep restriction therapy is an essential component of most behavioral treatments for insomnia. Moreover, little is known about the impact of CSR on sleep continuity and structure in healthy people whose need for sleep is satiated. We investigated the impact of CSR on sleep continuity and structure in nine healthy participants. They had 4 nights of sleep extension, 2 nights of post-extension sleep, 21 nights of CSR (5/5.6-hour time-in-bed), and 9 nights of recovery sleep. Compared to postextension sleep, during CSR sleep duration was reduced by 95.4 ± 21.2 min per night, Slow-Wave Activity was significantly increased, and sleep was more consolidated. During recovery, sleep duration was increased by 103.3 ± 23.8 min compared to CSR, and the CSR-induced increase in Slow-Wave Activity persisted, particularly after the 5-hour exposure. Yet, we found that sustained vigilant attention was not fully recovered even after nine nights of recovery sleep. Our results suggest that CSR improves traditional metrics of sleep quality and may have a persistent impact on sleep depth, which is consistent with the reported benefits on sleep continuity and structure of sleep restriction therapy. However, these improvements in traditional metrics of sleep quality were associated with deterioration rather than improvement in neurobehavioral performance, demonstrating that sleep duration should be included in assessments of sleep quality. These results have implications for the long-term use of sleep restriction in the behavioral treatment of insomnia. Clinical Trial Registration: Impact of Chronic Circadian Disruption vs. Chronic Sleep Restriction on Metabolism (https://clinicaltrials.gov/ct2/show/; #NCT02171273).
Identifiants
pubmed: 35218665
pii: 6537622
doi: 10.1093/sleep/zsac046
pmc: PMC9272266
pii:
doi:
Banques de données
ClinicalTrials.gov
['NCT02171273']
Types de publication
Clinical Trial
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIA NIH HHS
ID : F32 AG051325
Pays : United States
Organisme : NIA NIH HHS
ID : R44 AG056250
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK127254
Pays : United States
Organisme : NHLBI NIH HHS
ID : F32 HL143893
Pays : United States
Organisme : NIH HHS
ID : UL1 TR001102
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32HL007901
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001102
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG009975
Pays : United States
Organisme : NIA NIH HHS
ID : R43 AG056250
Pays : United States
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of Sleep Research Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Sleep. 2014 Feb 01;37(2):229-37
pubmed: 24497651
J Sleep Res. 2003 Mar;12(1):1-12
pubmed: 12603781
Sleep Med. 2011 Sep;12(8):735-47
pubmed: 21907616
Sleep. 2010 Aug;33(8):1037-42
pubmed: 20815184
J Clin Sleep Med. 2007 Aug 15;3(5):519-28
pubmed: 17803017
J Urol. 2014 Jan;191(1):100-6
pubmed: 23867307
Am J Physiol Endocrinol Metab. 2013 Oct 1;305(7):E890-6
pubmed: 23941878
Sleep. 2016 Jun 01;39(6):1233-40
pubmed: 27091536
Clin Neurophysiol. 2006 Sep;117(9):1885-901
pubmed: 16581292
Sleep. 2003 Mar 15;26(2):117-26
pubmed: 12683469
Sci Transl Med. 2010 Jan 13;2(14):14ra3
pubmed: 20371466
Sleep. 2018 Jul 1;41(7):
pubmed: 29722893
Physiol Rep. 2020 Jun;8(11):e14453
pubmed: 32519460
Sleep. 1993 Feb;16(2):100-13
pubmed: 8446828
Science. 2020 Oct 2;370(6512):50-56
pubmed: 33004510
Sleep. 1995 Dec;18(10):908-11
pubmed: 8746400
Neuroscience. 2006;138(1):351-6
pubmed: 16388912
Sleep. 2019 Feb 1;42(2):
pubmed: 30481333
J Occup Environ Med. 2016 Jul;58(7):683-9
pubmed: 27257747
Semin Neurol. 2005 Mar;25(1):117-29
pubmed: 15798944
Int J Environ Res Public Health. 2019 Feb 19;16(4):
pubmed: 30791379
Best Pract Res Clin Endocrinol Metab. 2010 Oct;24(5):731-43
pubmed: 21112022
Brain Sci. 2017 Mar 27;7(4):
pubmed: 28346384
Sleep. 2012 Jun 01;35(6):769-81
pubmed: 22654196
MMWR Morb Mortal Wkly Rep. 2009 Oct 30;58(42):1175-9
pubmed: 19875979
Sleep. 2009 Jul;32(7):905-13
pubmed: 19639753
Sleep. 2009 Feb;32(2):217-22
pubmed: 19238809
Sleep Sci. 2018 Mar-Apr;11(2):56-64
pubmed: 30083291
Sleep Med Rev. 2014 Oct;18(5):415-24
pubmed: 24629826
Sleep Med. 2006 Mar;7(2):123-30
pubmed: 16459140
Eur J Clin Pharmacol. 2020 Mar;76(3):363-381
pubmed: 31838549
Prog Brain Res. 2010;185:91-103
pubmed: 21075235
Sleep. 2014 Jan 01;37(1):117-26
pubmed: 24470701
Handb Exp Pharmacol. 2019;253:441-481
pubmed: 31254050
Proc Natl Acad Sci U S A. 2018 Jun 5;115(23):6070-6075
pubmed: 29784810